The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The APOE4 allele confers greater risk of Alzheimer’s Disease (AD) for women than men, in conjunction with greater clinical deficits per unit of AD neuropathology (plaques, tangles). Cerebral microbleeds, which contribute to cognitive dysfunctions during AD, also show APOE4 excess, but sex-APOE allele interactions are not described. We report that elderly men diagnosed for mild cognitive impairment (MCI) and AD showed a higher risk of cerebral cortex microbleeds with APOE4 allele dose effect in two clinical cohorts (ADNI and KIDS). Sex-APOE interactions were further analyzed in EFAD mice carrying human APOE alleles and familial AD genes. At 7 months, E4FAD mice had cerebral cortex microbleeds with female excess, in contrast to humans. Cerebral amyloid angiopathy (CAA), plaques, and soluble Aβ also showed female excess. Both the cerebral microbleeds and CAA increased in proportion to individual Aβ load. In humans, the opposite sex bias of APOE4 allele for microbleeds vs the plaques and tangles is the first example of organ-specific, sex-linked APOE allele effects, and further shows AD as a uniquely human condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 2×
“, 2015) which is increased by APOE4 (Bell et al., 2012) could contribute to preclinical Ab.”
BackgroundNeurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · cited 1×
“We also assayed oligomeric Ab, a driver of neurodegeneration in AD (Klein et al., 2001; Mucke and Selkoe, 2012), which has not been reported for associations with sex or APOE in mouse models.”
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Sex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891 · cited 4×
“5% faster brain atrophy in magnetic resonance imaging (MRI) studies of probable AD (Hua et al., 2010), and higher tau in cerebrospinal fluid of prodromal AD (mild cognitive impairment [MCI]) (Altmann et al., 2014), but also in cognitively healthy elderly (Damoiseaux et al., 2012).”
BackgroundResultInfluentialBerg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · cited 2×
“APOE4 associations with CAA as reported (Berg et al., 1998; Nelson et al., 2013; Olichney et al., 2000; Premkumar et al., 1996; Walker et al., 2000; Yip et al., 2005), however, were not replicated by others (Love et al., 2003; Xu et al., 2003).”
ResultSex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603
Sullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575 · cited 1×
“(The FAD non-carriers with human APOE in the present studies are not identical with the original APOE-TR of Sullivan et al., 1997 because of their derivation via backcrossing with the 5XFADwhich is on a different background strain).”
ResultSelf-citationRaber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., Mahley, R. W., & Mucke, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10914 · Cited by 364 · cited 1×
“Mice were examined at age 6e7months, when the female bias in behavioral deficits emerges in the NSE-APOE mouse (Raber et al., 1998).”
MethodJeerakathil, T., Wolf, P. A., Beiser, A., Hald, J. K., Au, R., Kase, C. S., Massaro, J. M., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000131809.35202.1b · Cited by 319
Fryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278 · cited 2×
“FAD mice develop CAA (Fryer et al., 2005) but sex differences and interactions of FAD with human APOE transgenes are not reported.”
BackgroundResultSelf-citationCarroll, J. C., Rosario, E. R., Kreimer, S., Villamagna, A., Gentzschein, E., Stanczyk, F. Z., & Pike, C. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.009 · Cited by 273
Self-citationAPOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Youmans, K. L., Tai, L. M., Nwabuisi-Heath, E., Jungbauer, L., Kanekiyo, T., Gan, M., Kim, J., Eimer, W. A., Estus, S., Rebeck, G. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407957 · Cited by 268 · cited 8×
“Oligomeric Ab was assayed in Tris extracts by oligospecific MOAB-2 enzyme-linked immunosorbent assay (monoclonal antibody; Youmans et al., 2012) (Biosensis, Thebarton, Australia).”
BackgroundMethodInfluentialSelf-citationDamoiseaux, J. S., Seeley, W. W., Zhou, J., Shirer, W. R., Coppola, G., Karydas, A., Rosen, H. J., Miller, B. L., Kramer, J. H., Greicius, M. D., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0305-12.2012 · Cited by 267
Early androgen exposure and human gender development
Hines, M., Constantinescu, M., & Spencer, D. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0022-1 · Cited by 263
Gender, sex steroid hormones, and Alzheimer’s disease
Vest, R. S., & Pike, C. J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.006 · Cited by 260 · cited 1×
“Mouse transgenic models of AD with familial AD mutations (FAD) have shown consistent female excess of brain Ab and cognitive deficits (Carroll et al., 2010; Dubal et al., 2012; Sturchler-Pierrat and Staufenbiel, 2000; Vest and Pike, 2013).”
BackgroundSelf-citationCORDER, E. H., GHEBREMEDHIN, E., TAYLOR, M. G., THAL, D. R., OHM, T. G., & BRAAK, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.005 · Cited by 254 · cited 7×
“This sex bias is opposite to the >50% higher risk of AD in women carrying APOE4 (Altmann et al., 2014; Corder et al., 2004).”
BackgroundResultInfluentialSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234 · cited 2×
“5% faster brain atrophy in magnetic resonance imaging (MRI) studies of probable AD (Hua et al., 2010), and higher tau in cerebrospinal fluid of prodromal AD (mild cognitive impairment [MCI]) (Altmann et al., 2014), but also in cognitively healthy elderly (Damoiseaux et al., 2012).”
BackgroundAttems, J., Jellinger, K. A., & Lintner, F. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1064-y · Cited by 188
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy
Reijmer, Y. D., Fotiadis, P., Martinez-Ramirez, S., Salat, D. H., Schultz, A., Shoamanesh, A., Ayres, A. M., Vashkevich, A., Rosas, D., Schwab, K., et al. (2015) · Brain · doi:10.1093/brain/awu316 · Cited by 181
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J., & Mirra, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9382 · Cited by 179 · cited 2×
“Although aging great apes develop CAA (Gearing et al., 1994) and incur sporadic strokes (Jean et al.”
BackgroundAPOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature
Nelson, P. T., Pious, N. M., Jicha, G. A., Wilcock, D. M., Fardo, D. W., Estus, S., & Rebeck, G. W. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829a25b9 · Cited by 150 · cited 1×
“APOE4 associations with CAA as reported (Berg et al., 1998; Nelson et al., 2013; Olichney et al., 2000; Premkumar et al., 1996; Walker et al., 2000; Yip et al., 2005), however, were not replicated by others (Love et al., 2003; Xu et al., 2003).”
ResultIncidence of cerebral microbleeds in preclinical Alzheimer disease
Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150
Han, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4686-08.2008 · Cited by 138 · cited 3×
“These Ab-microbleed correlations extend those for single FAD gene transgenic mice with endogenous murine APOE, inwhich vascular Ab levels in leptomeningeal arteries correlated with impaired vasodilation (sex unspecified) (Han et al., 2008; Zipfel et al., 2009).”
BackgroundShams, S., Martola, J., Granberg, T., Li, X., Shams, M., Fereshtehnejad, S. M., Cavallin, L., Aspelin, P., Kristoffersen-Wiberg, M., & Wahlund, L. O. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4176 · Cited by 132
Self-citationFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Neuroprotective Sirtuin ratio reversed by ApoE4
Theendakara, V., Patent, A., Peters Libeu, C. A., Philpot, B., Flores, S., Descamps, O., Poksay, K. S., Zhang, Q., Cailing, G., Hart, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314145110 · Cited by 101
Commentary: is Alzheimer's disease uniquely human?
Finch, C. E., & Austad, S. N. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.025 · Cited by 72 · cited 1×
“Moreover, APOE4 may be adaptive in immunity by higher cytokine responses (Finch and Morgan, 2007) and in pathogen resistance (Azevedo et al., 2014; Finch and Martin, 2015; Rougeron et al., 2013).”
BackgroundSelf-citationCerebral Vascular Leak in a Mouse Model of Amyloid Neuropathology
Tanifum, E. A., Starosolski, Z. A., Fowler, S. W., Jankowsky, J. L., & Annapragada, A. V. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.125 · Cited by 28
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Sex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
“mo; not studied before 9 mo Cortex Park et al., 2017 2 mo Not studied 4–5 mo Oakley et al., 2006; Webster et al., 2014 Loss of LRP1 endothelial expression 7 mo; not studied before 7 mo Cortex Storck et al., 2016 Loss of GLUT1 endothelial expression, increased RAGE vascular expression, increased MMP-9 vascular expressi…”
BackgroundInfluentialVeitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Metadata
- Authors
- Cacciottolo, M., Christensen, A., Moser, A., Liu, J., Pike, C. J., Smith, C., LaDu, M. J., Sullivan, P. M., Morgan, T. E., Dolzhenko, E., Charidimou, A., Wahlund, L.-O., Wiberg, M. K., Shams, S., Chiang, G. C.-Y., & Finch, C. E.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 37
- Pages
- 47-57
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W1838346586
- Cited by
- 93
- References
- 34
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.